These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27016110)

  • 1. Evaluation of cisterna chyli diameter with MRI in patients with chronic kidney disease.
    Albayrak E; Ozmen Z; Sahin S; Demir O; Erken E
    J Magn Reson Imaging; 2016 Oct; 44(4):890-6. PubMed ID: 27016110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisterna chyli in autosomal dominant polycystic kidney disease.
    Thimmappa ND; Blumenfeld JD; Cerilles MA; Dunning A; Donahue SL; Bobb WO; Zhang HL; Prince MR
    J Magn Reson Imaging; 2015 Jan; 41(1):142-8. PubMed ID: 24470398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisterna chyli in patients with portal hypertension: evaluation with MR imaging.
    Ito K; Shimizu A; Tanabe M; Matsunaga N
    J Magn Reson Imaging; 2012 Mar; 35(3):624-8. PubMed ID: 22069241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisterna chyli in patients with malignancy--influence of cardiovascular disease on the prevalence of the cisterna.
    Feuerlein S; Stolz J; Muche R; Hetzel M; Klass O; Brambs HJ; Pauls S
    Eur J Radiol; 2011 Aug; 79(2):262-5. PubMed ID: 20223610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisterna chyli in patients with malignancy--is there a correlation between changes in cisterna volume and progression or regression of the tumor?
    Feuerlein S; Kern M; Muche R; Ernst AS; Juchems MS; Pauls S
    Eur J Radiol; 2010 Nov; 76(2):177-9. PubMed ID: 19540693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudotumours in chronic kidney disease: can diffusion-weighted MRI rule out malignancy.
    Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A
    Eur J Radiol; 2013 Nov; 82(11):1870-6. PubMed ID: 23932396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ultrasonographic chronic kidney disease score in the assessment of chronic kidney disease.
    Yaprak M; Çakır Ö; Turan MN; Dayanan R; Akın S; Değirmen E; Yıldırım M; Turgut F
    Int Urol Nephrol; 2017 Jan; 49(1):123-131. PubMed ID: 27796695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted imaging in assessing renal pathology of chronic kidney disease: A preliminary clinical study.
    Li Q; Li J; Zhang L; Chen Y; Zhang M; Yan F
    Eur J Radiol; 2014 May; 83(5):756-62. PubMed ID: 24581595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dilated cisternae chyli: a sign of uncompensated cirrhosis at MR imaging.
    Verma SK; Mitchell DG; Bergin D; Lakhman Y; Austin A; Verma M; Assis D; Herrine SK; Parker L
    Abdom Imaging; 2009; 34(2):211-6. PubMed ID: 18219518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can renal sonography be a reliable diagnostic tool in the assessment of chronic kidney disease?
    Lucisano G; Comi N; Pelagi E; Cianfrone P; Fuiano L; Fuiano G
    J Ultrasound Med; 2015 Feb; 34(2):299-306. PubMed ID: 25614403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal confluence of lymph trunks: detectability and morphology on heavily T2-weighted images.
    Erden A; Fitoz S; Yagmurlu B; Erden I
    AJR Am J Roentgenol; 2005 Jan; 184(1):35-40. PubMed ID: 15615947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological features and clinical feasibility of thoracic duct: detection with nonenhanced magnetic resonance imaging at 3.0 T.
    Yu DX; Ma XX; Zhang XM; Wang Q; Li CF
    J Magn Reson Imaging; 2010 Jul; 32(1):94-100. PubMed ID: 20578016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of renal function in chronic kidney disease (CKD) by mDIXON-Quant and Amide Proton Transfer weighted (APTw) imaging.
    Ju Y; Wang Y; Luo RN; Wang N; Wang JZ; Lin LJ; Song QW; Liu AL
    Magn Reson Imaging; 2023 Nov; 103():102-108. PubMed ID: 37451519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cisterna chyli: enhancement on delayed phase MR images after intravenous administration of gadolinium chelate.
    Verma SK; Mitchell DG; Bergin D; Mehta R; Chopra S; Choi D
    Radiology; 2007 Sep; 244(3):791-6. PubMed ID: 17652192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed tomography and magnetic resonance imaging are potential noninvasive methods for evaluating the cisterna chyli in cats.
    Martín NG; Miño ED
    J Am Vet Med Assoc; 2024 Jan; 262(1):1-7. PubMed ID: 37770017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging appearance of the Cisterna chyli.
    Johnson VS; Seiler G
    Vet Radiol Ultrasound; 2006; 47(5):461-4. PubMed ID: 17009507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant cisterna chyli: MRI depiction with gadolinium-DTPA enhancement.
    Lee KC; Cassar-Pullicino VN
    Clin Radiol; 2000 Jan; 55(1):51-5. PubMed ID: 10650111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postural effect on the size of the cisterna chyli.
    Niggemann P; Förg A; Grosskurth D; Beyer HK
    Lymphat Res Biol; 2010 Dec; 8(4):193-7. PubMed ID: 21190491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Renal Oxygenation with Renal Function in Chronic Kidney Disease: A Preliminary Prospective Study.
    Xu Y; Yang J; Lu F; Ye C; Wang C
    Kidney Blood Press Res; 2023; 48(1):175-185. PubMed ID: 36791684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance elastography for evaluation of renal parenchyma in chronic kidney disease: a pilot study.
    Han JH; Ahn JH; Kim JS
    Radiol Med; 2020 Dec; 125(12):1209-1215. PubMed ID: 32367323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.